Lifestyle modification in metabolic syndrome and associated changes in plasma amino acid profiles

Circulation Journal

Volumn 74, Issue 11, 2010, Pages 2434-2440

  Kamaura, Mitsumas ^a   Nishijima, Kiyoko ^c   Takahashi, Mitsuo ^b   Ando, Toshihiko ^b   Mizushima, Shunsaku ^c   Tochikubo, Osamu ^c  

^a Kanagawa Health Service Association   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Amino acid; Lifestyle modification; Metabolic syndrome

Indexed keywords

ALANINE; AROMATIC AMINO ACID; ASPARAGINE; GLUTAMIC ACID; GLYCINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROLINE; SERINE; THREONINE; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINOINDEX; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; HUMAN; JAPANESE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NUTRITIONAL COUNSELING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; AMINO ACIDS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; COUNSELING; DIET; DISCRIMINANT ANALYSIS; EXERCISE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK REDUCTION BEHAVIOR; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 78349286984     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0150     Document Type: Article

References (36)

1. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24: e13-e18.
3. Kobayashi H, Nakamura T, Miyaoka K, Nishida M, Funahashi T, Yamashita S, et al. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J 2001; 65: 193-199.
4. Shimabukuro M. Cardiac adiposity and global cardiometabolic risk: New concept and clinical implication. Circ J 2009; 73: 27-34.
5. Kokubo Y, Kamide K. High-normal blood pressure and the risk of cardiovascular disease. Circ J 2009; 73: 1381-1385.
6. Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S, et al. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J 2008; 49: 193-203.
7. Shimbo K, Kubo S, Harada Y, Oonuki T, Yokokura T, Yoshida H, et al. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry. Biomed Chromatogr 2010; 24: 683-691.
8. Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975; 78: 276-290.
9. Zhang Q, Takahashi M, Noguchi Y, Sugimoto T, Kimura T, Okumura A, et al. Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infection. Hepatol Res 2006; 34: 170-177.
10. Felig P, Marliss E, Cahill GF Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969; 281: 811-816.
11. Felig P, Marliss E, Ohman JL, Cahill CF Jr. Plasma amino acid levels in diabetic ketoacidosis. Diabetes 1970; 19: 727-728.
12. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL. The largescale organization of metabolic networks. Nature 2000; 407: 651-654.
13. Wagner A, Fell DA. The small world inside large metabolic networks. Proc Biol Sci 2001; 268: 1803-1810.
14. Kimura T, Noguchi Y, Shikata N, Takahashi M. Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr Opin Clin Nutr Metab Care 2009; 12: 49-53.
15. Noguchi Y, Zhang QW, Sugimoto T, Furuhata Y, Sakai R, Mori M, et al. Network analysis of plasma and tissue amino acids and the generation of an amino index for potential diagnostic use. Am J Clin Nutr 2006; 83: 513S-519S.
16. The Examination Committee of Criteria for Metablic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Int Med 2005; 94: 794-809 (in Japanese).
17. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
18. Chevalier S, Burgess SC, Malloy CR, Gougeon R, Marliss EB, Morais JA. The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 2006; 55: 675-681.
19. Meijer AJ, Lamers WH, Chamuleau RA. Nitrogen metabolism and ornithine cycle function. Physiol Rev 1990; 70: 701-748.
20. Morris SM Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002; 22: 87-105.
21. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-749.
22. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728.
23. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. Role of L-arginine-nitric oxide pathway in hypertension. J Hypertens 1993; 11: 639-645.
24. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
25. Keys JR, Koch WJ. The adrenergic pathway and heart failure. Recent Prog Horm Res 2004; 59: 13-30.
26. Mark AL. Regulation of sympathetic nerve activity in mild human hypertension. J Hypertens Suppl 1990; 8: S67-S75.
27. Watanabe M, Suliman ME, Qureshi AR, Garcia-Lopez E, Barany P, Heimburger O, et al. Consequences of low plasma histidine in chronic kidney disease patients: Associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr 2008; 87: 1860-1866.
28. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. JAMA 1997; 277: 1775-1781.
29. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
30. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, et al. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 2006; 100: 1657-1665.
31. Roberts CK, Won D, Pruthi S, Lin SS, Barnard RJ. Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. Diabetes Res Clin Pract 2006; 73: 249-259.
32. Cynober LA, editor. Metabolic and therapeutic aspects of amino acids in clinical nutrition. CRC Press; 2004.
33. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806.
34. Avruch J, Long X, Ortiz-Vega S, Rapley J, Papageorgiou A, Dai N. Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab 2009; 296: E592-E602.
35. Rennie MJ, Bohe J, Smith K, Wackerhage H, Greenhaff P. Branched-chain amino acids as fuels and anabolic signals in human muscle. J Nutr 2006; 136: 264S-268S.
36. Takahashi M, Ando T, Ishizaka Y, Tani M, Yamakado M. Usefulness of measurement of plasma amino acid at Ningen Dock(1): Diagnosis of metabolic syndrome. NINGEN DOCK: OFFICIAL JOURNAL OF THE JAPANESE SOCIETY OF NINGEN DOCK, 2006; 21, 417 (in Japanese).